Clinical efficacies, underlying mechanisms and molecular targets of Chinese medicines for diabetic nephropathy treatment and management
Year: 2021
Type: review
Abstract: Diabetic nephropathy (DN) has been recognized as a severe complication of diabetes mellitus and a dominant pathogeny of end-stage kidney disease, which causes serious health problems and great financial burden to human society worldwide. Conventional strategies, such as renin-angiotensin-aldosterone system blockade, blood glucose level control, and bodyweight reduction, may not achieve satisfactory outcomes in many clinical practices for DN management. Notably, due to the multi-target function, Chinese medicine possesses promising clinical benefits as primary or alternative therapies for DN treatment. Increasing studies have emphasized identifying bioactive compounds and molecular mechanisms of reno-protective effects of Chinese medicines. Signaling pathways involved in glucose/lipid metabolism regulation, antioxidation, anti-inflammation, anti-fibrosis, and podocyte protection have been identified as crucial mechanisms of action. Herein, we summarize the clinical efficacies of Chinese medicines and their bioactive components in treating and managing DN after reviewing the results demonstrated in clinical trials, systematic reviews, and meta-analyses, with a thorough discussion on the relative underlying mechanisms and molecular targets reported in animal and cellular experiments. We aim to provide comprehensive insights into the protective effects of Chinese medicines against DN.
Source: Acta Pharmaceutica Sinica B
Institution: University of Hong Kong
Language: English
Subfield: Nephrology
Field: Medicine
Domain: Health Sciences
Keywords: diabetic nephropathy, traditional Chinese medicine, herbal medicine, renal protection, bioactive compounds, molecular mechanisms, signaling pathways, glycolipid metabolism, anti-oxidation, anti-inflammation, renal fibrosis, podocyte protection, end-stage renal disease, complementary and alternative medicine
Open Access status: gold
Estimated APC paid: $2,600
Awards: G1495353389, G3140755072, G3456089611, Berberine suppresses metastasis and recurrence of hepatocellular carcinoma via targeting circulating tumour cells, G5005347620, Heat-cooling Chinese herbs in treating chronic hepatitis B patients comparing with antiviral therapy: A systematic review and network meta-analysis, Investigation on the effect of berberine on improvement of diabetic retinopathy in insulin-treated diabetic mellitus, G6056815827, G7572284868
OpenAlex ID: W3127843453
